14 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

  • Hepion Pharmaceuticals, Inc. HEPA shares increased by 86.0% to $4.65 during Thursday's pre-market session. The market cap seems to be at $9.3 million.
  • Cronos Group, Inc. CRON shares rose 16.7% to $9.80. The market cap stands at $4.1 billion. The most recent rating by Piper Jaffray, on August 13, is at Overweight, with a price target of $18.00.
  • Seelos Therapeutics, Inc. SEEL shares surged 11.8% to $1.10. The market cap seems to be at $28.0 million.
  • Zealand Pharma, Inc. ZEAL shares rose 8.3% to $27.07. The most recent rating by Goldman Sachs, on October 15, is at Buy, with a price target of $41.00.
  • Canopy Growth, Inc. CGC stock rose 4.7% to $20.65. The market cap seems to be at $11.0 billion. According to the most recent rating by Seaport Global, on October 14, the current rating is at Neutral.
  • Titan Pharmaceuticals, Inc. TTNP stock rose 2.2% to $0.18. The market cap stands at $4.2 million.
  • Teva Pharmaceutical Indus, Inc. TEVA shares surged 1.9% to $7.07. According to the most recent rating by Gabelli & Co., on October 17, the current rating is at Buy.
  • Qiagen, Inc. QGEN shares moved upwards by 1.8% to $28.04. The market cap seems to be at $7.4 billion. According to the most recent rating by Kepler Cheuvreux, on October 09, the current rating is at Reduce.
  • Genmab, Inc. GMAB stock surged 1.7% to $20.93. The most recent rating by HC Wainwright & Co., on October 16, is at Buy, with a price target of $25.00.
  • Novo Nordisk, Inc. NVO stock increased by 1.5% to $53.08. The most recent rating by KeyBanc, on October 07, is at Overweight, with a price target of $14.00.
  • Sanofi, Inc. SNY stock moved upwards by 1.0% to $46.19. According to the most recent rating by Guggenheim, on September 23, the current rating is at Buy.
 

 

Losers

  • Bionano Genomics, Inc. BNGO stock declined 21.8% to $2.23 during Thursday's pre-market session. The market value of their outstanding shares is at $7.6 million.
  • Viveve Medical, Inc. VIVE stock decreased by 13.2% to $4.60. The market value of their outstanding shares is at $2.6 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • Ocugen, Inc. OCGN shares fell 1.0% to $2.05. The market cap seems to be at $4.4 million.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!